Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.8B | 5.5B | 8.0B | 5.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 3.3B | 3.3B | 4.5B | 3.7B |
| Other operating expenses | 232M | 241M | 194M | 183M |
| Operating income | 1.1B | 1.7B | 3.2B | 1.9B |
| Non operating interest income | ||||
| Income | 241M | 251M | 327M | 293M |
| Expense | 649M | 507M | 305M | 264M |
| Other income expense | -258M | 91M | -332M | 37M |
| Pretax income | 396M | 1.6B | 2.9B | 1.9B |
| Tax provision | 63M | 496M | 352M | 401M |
| Net income | 333M | 1.1B | 2.5B | 1.5B |
| Basic EPS | — | 0.2 | 0.4 | 0.2 |
| Diluted EPS | — | 0.2 | 0.4 | 0.2 |
| Basic average shares | — | 6.6B | 6.7B | 6.8B |
| Diluted average shares | — | 6.7B | 6.8B | 6.9B |
| EBITDA | 1.5B | 1.7B | 3.7B | 2.3B |
| Net income from continuing op. | 333M | 1.1B | 2.5B | 1.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |